Citing a potential threat to public health, the agency in December asked 26 companies to voluntarily stop labeling drugs important for treating human infection as acceptable for animal growth promotion. The FDA did not name the one company that has not agreed to withdraw or revise its drugs.
More
More
No comments:
Post a Comment